RBC Capital Maintains Underperform on Box, Lowers Price Target to $21

RBC Capital analyst Rishi Jaluria maintains Box (NYSE:BOX) with a Underperform and lowers the price target from $24 to $21.

byBenzinga Newsdesk

March 15, 2023

1 minute read

RBC Capital analyst Rishi Jaluria maintains Box (NYSE:BOX) with a Underperform and lowers the price target from $24 to $21.

Goldman Sachs Analyst Downgrades IMAX And Cinemark: What You Need To Know

By Phil Hall

June 2, 4:34 PM

Goldman Sachs Vice President of Global Investment Research Michael Ng downgraded two major film exhibitors, Imax Corp (NYSE: IMAX) and Cinemark Holdings, Inc. (NYSE: CNK), in a newly published analysis.

CNK

Goldman Sachs Maintains Buy on Prometheus Biosciences, Raises Price Target to $144

By Benzinga Newsdesk

January 31, 10:22 AM

Goldman Sachs analyst Chris Shibutani maintains Prometheus Biosciences (NASDAQ:RXDX) with a Buy and raises the price target from $117 to $144.

RXDX

Hertz Shares Up 12%; Stock Broke Above $23 Level, Upside Has Intensified Since; Recent Barron’s Article ‘Hertz Deal for Preferred Could Mean a Big Buyback Ahead’ Highlighted Earlier Comments From Analyst At Odeon Capital

By Benzinga Newsdesk

November 24, 3:59 PM

A deal by Hertz Global Holdings to repurchase the bulk of its $1.5 billion of preferred stock could pave the way for a large stock repurchase program. The prospect of a sizable buyback is

HTZ